Supporting Indian Biotherapeutic Companies with Antibody Development

Posted on

Fusion Antibodies and BioTickle partnership delivers value with proprietary antibody discovery, engineering and cell line technologies Belfast, UK – (22 July 2021) – Fusion Antibodies, pre-clinical antibody discovery and development experts and BioTickle, their exclusive distributor in India, are providing local biopharmaceutical organisations with access to invaluable unique biopharmaceutical development capabilities. As Dr Richard Jones, […]

Stepping outside of the CDR to create naturalised libraries and humanized antibodies

Posted on

With their high specificity, efficacy and safety profiles, it’s no wonder that antibodies have become the biggest selling drugs in recent years. Advances in antibody discovery, selection and manufacturing have catapulted therapeutic antibodies to become the primary treatment for several diseases and the market shows no sign of abating, with the industry expected to be […]

Fusion Antibodies